ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

Hopkins, Pennsylvania Ok’d As Comprehensive; No. Remains At 24

May 24, 1991

Nexon Heads Kennedy Committee Health Staff: Pepper Introduces Bill For May As “NCI Month”

January 16, 1987

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

October 30, 1998

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993